Talymed® Ensures Fast, Easy Wound Management for a Broad Range of Indications
Talymed's powerful healing properties have been shown to speed the healing process and provide complete wound healing for a broad indication of wound management. The product's efficacy is supported by documented case studies and peer-reviewed literature. To learn more, contact us today.
- Successful treatment of two refractory venous stasis ulcers treated with a novel poly-N-acetyl glucosamine-derived membrane Maus, EA. BMJ Case Reports 2012; doi:10.1136/bcr.03.2012.6091
- Clinical and cost efficacy of advanced wound care matrices for venous ulcers Hankin CS, Knispel J, Lopes M, Bronstone A, Maus E. J Manag Care Pharm. 2012 Jun;18(5):375-84
- A Randomized, Investigator-Blinded, Controlled Pilot Study to Evaluate the Safety and Efficacy of a Poly-N-Acetyl Glucosamine–Derived Membrane Material in Patients with Venous Leg Ulcers Kelechi T, Mueller M, Hankin C, et al. J Am Acad Dermatol, 2011 May 25.
Indications for Use:
Talymed® is indicated for the management of wounds including: diabetic ulcers, venous ulcers, pressure wounds, ulcers caused by mixed vascular etiologies, full thickness and partial thickness wounds, second degree burns, surgical wounds-donor sites/grafts, post-mohs surgery, post-laser surgery, and other bleeding surface wounds, abrasions, lacerations, traumatic wounds healing by secondary intention, chronic vascular ulcers, dehisced surgical wounds.
Safety Information:
PRECAUTIONS: There are no known contraindications to the use of Talymed®.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner.
Manufactured by Marine Polymer Technologies, Inc. For instructions for use or additional product information, please contact us.
- 9,139,664
- 9,139,663
- 8,871,247
Talymed® - Ordering Information:
| Item # | Description | Matrix Size |
|---|---|---|
| 400-20 | Talymed 5 cm x 5 cm | 25 sq cm |
| 400-35 | Talymed 3 cm x 3 cm | 9 sq cm |